MedPath

Impact of "Telecoaching Program" on Physical Activity in Patients With COPD

Not Applicable
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Other: Coaching program
Registration Number
NCT02158065
Lead Sponsor
KU Leuven
Brief Summary

The purpose of this 3 month randomized intervention study is to investigate the additional effect of a physical activity telecoaching program on physical activity in patients with COPD, compared with usual care.

Detailed Description

In this 3 month, randomized (1:1 ratio), parallel-group, multicenter trial, patients in both groups (control and coaching) will receive information and guidance on the benefits associated with increased physical activity in COPD patients and their health status. Patients in both groups will use two PROactive monitors (ActiGraph® and DynaPort®) and a PDA to complete the PROactive questionnaire. In addition to above, the patients in the coaching group will receive daily coaching by a semiautomated system and coaching by the investigator during study visits.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
370
Inclusion Criteria
  • Written informed consent must be obtained before any assessment is performed
  • Male and female patients ≥ 40 years of age
  • Diagnosis of COPD (GOLD criteria: post bronchodilator FEV1/FVC< 70%)
  • Current or ex-smokers with a smoking history equivalent to at least 10 pack years
  • Patient should have at least 4 days of physical activity data recorded via PROactive monitors during 7 days prior to the baseline measurement
Exclusion Criteria
  • Orthopedic, neurological or other complaints that significantly impair normal biomechanical movement patterns, as judged by the investigator. Specifically if the patients' condition/ co-morbidities are such that physical activity cannot be increased, then they should not be enrolled
  • Respiratory diseases other than COPD (e.g. asthma)
  • Cognitive reading impairment and/or difficulties to manage electronic devices precluding interaction with the smartphone and PDA, as judged by the investigator
  • Participating in or scheduled to start an outpatient rehabilitation program during the study. If the patient wishes to participate in pulmonary rehabilitation for any reason the patient can be enrolled in the study only at the end of rehabilitation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Coaching programCoaching programIn addition to usual care, patients will receive the coaching program
Primary Outcome Measures
NameTimeMethod
Daily number of stepschanges from baseline to 3 months

The daily number of steps will be measured by the PROactive monitors (ActiGraph® and DynaPort®) at baseline (during the week prior to baseline visit) and at the end of the 3-month epoch (during the week prior to end visit).

Secondary Outcome Measures
NameTimeMethod
6-minute walking testchanges from baseline to 3 months
Time spent in at least moderate physical activitychanges from baseline to 3 months

Time in at least moderate physical activity will be measured by the PROactive monitors (ActiGraph® and DynaPort®) at baseline (during the week prior to baseline visit) and at the end of the 3-month epoch (during the week prior to end visit).

isometric Quadriceps forcechanges from baseline to 3 months
COPD symptoms and health-related quality of lifechanges form baseline to 3 months

COPD symptoms and health-related quality of life will be measured by the CAT, CCQ, HADS and mMRC questionnaires

Proportion of patients showing an increase of physical activity by >20%changes from baseline to 3 months

Physical activity will be measured by the PROactive monitors (ActiGraph® and DynaPort®) at baseline (during the week prior to baseline visit) and at the end of the 3-month epoch (during the week prior to end visit).

Trial Locations

Locations (6)

KULeuven

🇧🇪

Leuven, Belgium

Thorax Research Foundation

🇬🇷

Athens, Greece

University of Zurich

🇨🇭

Zurich, Switzerland

University Medical Center

🇳🇱

Groningen, Netherlands

Royal Brompton Hospital, Imperial College

🇬🇧

London, United Kingdom

University of Edinburgh

🇬🇧

Edinburgh, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath